These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3448267)

  • 21. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes.
    Inou Y; Nakayama T; Yoshida N; Uejima H; Yuri K; Kamada M; Kumagai T; Sakiyama H; Miyata A; Ochiai H; Ihara T; Okafuji T; Okafuji T; Nagai T; Suzuki E; Shimomura K; Ito Y; Miyazaki C
    J Med Virol; 2004 May; 73(1):97-104. PubMed ID: 15042655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus.
    Shah D; Vidal S; Link MA; Rubin SA; Wright KE
    J Med Virol; 2009 Jan; 81(1):130-8. PubMed ID: 19031463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mumps virus infection of the developing mouse brain--appearance of structural virus proteins demonstrated with monoclonal antibodies.
    Kristensson K; Orvell C; Malm G; Norrby E
    J Neuropathol Exp Neurol; 1984 Mar; 43(2):131-40. PubMed ID: 6368757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.
    Wolinsky JS; Waxham MN; Server AC
    J Virol; 1985 Mar; 53(3):727-34. PubMed ID: 3973964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inclusion body myositis: the mumps virus hypothesis.
    Nishino H; Engel AG; Rima BK
    Ann Neurol; 1989 Mar; 25(3):260-4. PubMed ID: 2729916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of mumps virus invasiveness in monkeys.
    Rozina EE; Kaptsova TI; Sharova OK; Nikolaeva MA; Nesterova TP
    Acta Virol; 1984 Mar; 28(2):107-13. PubMed ID: 6145343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of mumps virus strains with varying neurovirulence.
    Rafiefard F; Johansson B; Tecle T; Orvell C
    Scand J Infect Dis; 2005; 37(5):330-7. PubMed ID: 16051568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies against the nucleoprotein of mumps virus: their binding characteristics and cross-reactivity with other paramyxoviruses.
    Tsurudome M; Yamada A; Hishiyama M; Ito Y
    Acta Virol; 1990 May; 34(3):220-7. PubMed ID: 1980395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple detection of mumps virus neuraminidase and anti-neuraminidase with the lectin neuraminidase test.
    Luther P; Klamm H; Weber S
    Acta Virol; 1983 Jan; 27(1):89-91. PubMed ID: 6133438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 2. NDV and mumps virus haemolysis-inhibiting antibodies.
    Orvell C
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):451-7. PubMed ID: 998262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inactivation of hemagglutinin and neuraminidase on mumps virus.
    Leprat R; Aymard M
    Arch Virol; 1979; 61(4):273-81. PubMed ID: 518302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of mutants of mumps virus with altered structure and pathogenicity by passage in vivo.
    Löve A; Rydbeck R; Ljungdahl A; Kristensson K; Norrby E
    Microb Pathog; 1986 Apr; 1(2):149-58. PubMed ID: 3508486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
    Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
    Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Two patients with mumps].
    van Brummelen SE; de Vries E; Schneeberger PM; van Binnendijk RS; Lestrade P; Wever PC
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1732-5. PubMed ID: 16924947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of mumps virus genome and application of the PCR for identification of the mumps virus strains].
    Tanabayashi K; Yamada A
    Nihon Rinsho; 1992 Jul; 50 Suppl():244-9. PubMed ID: 1404910
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional outbreak of mumps due to genotype H in Korea in 1999.
    Lee JY; Na BK; Kim JH; Lee JS; Park JW; Shin GC; Cho HW; Lee HD; Gou UY; Yang BK; Kim J; Kang C; Kim WJ
    J Med Virol; 2004 May; 73(1):85-90. PubMed ID: 15042653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis.
    Löve A; Rydbeck R; Utter G; Orvell C; Kristensson K; Norrby E
    J Virol; 1986 Apr; 58(1):220-2. PubMed ID: 3754016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin-independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells.
    Härfast B; Andersson T; Perlmann P
    J Immunol; 1978 Aug; 121(2):755-61. PubMed ID: 308078
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells.
    Moolten FL; Cooperband SR
    Science; 1970 Jul; 169(3940):68-70. PubMed ID: 4986716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.